NCM · Financial Statements

CervoMed Inc. (CRVO) Financial Statements

$2.31 NCM: CRVO Market Cap $34.93M

CervoMed Inc. most recently reported annual revenue of $0, a net loss of $27.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

CervoMed Inc.: net profit was positive in 0 of 10 reported years; the most recent year shows a net loss of $27.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$0$0$0$0$0$0$0$0$0$0
Operating Expenses$15.0M$11.0M$12.0M$12.0M$16.0M$25.0M$3.0M$8.0M$18.0M$28.0M
Operating Profit$-15.0M$-11.0M$-12.0M$-12.0M$-16.0M$-25.0M$-3.0M$-8.0M$-18.0M$-28.0M
Operating Margin0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Other Income$-4.0M$9.0M$-7.0M$0$0$0$-2.0M$6.0M$2.0M$1.0M
Interest$0$3.0M$0$0$0$0$0$0$0$0
Depreciation$0$0$0$0$0$0$0$0$0$0
Profit Before Tax$-18.0M$-2.0M$-19.0M$-11.0M$-16.0M$-25.0M$-6.0M$-2.0M$-16.0M$-27.0M
Tax$2.0M$43.6M$2.3M$-2.9M$10.6M$1.8M$0$0$0$0
Net Profit$-18.0M$-1.0M$-18.0M$-12.0M$-14.0M$-24.0M$-6.0M$-2.0M$-16.0M$-27.0M
EPS$-1982.96$-120.35$-424.93$-131.95$-22.50$-18.51$-11.20$-0.82$-2.02$-2.98
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$0$0$0$0$0$0$0$0$0$0$0$0
Operating Expenses$3.0M$2.0M$3.0M$3.0M$5.0M$7.0M$5.0M$7.0M$8.0M$8.0M$8.0M$7.0M
Operating Profit$-3.0M$-2.0M$-3.0M$-3.0M$-5.0M$-7.0M$-5.0M$-7.0M$-8.0M$-8.0M$-8.0M$-7.0M
Operating Margin0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%-2493.8%0.0%0.0%0.0%
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax$2.0M$-2.0M$-3.0M$-2.0M$-5.0M$-7.0M$-5.0M$-6.0M$-8.0M$-8.0M$-8.0M$-7.0M
Tax$0$0$0$0$0$0$0$0$0$0$0$0
Net Profit$2.0M$-2.0M$-3.0M$-2.0M$-5.0M$-7.0M$-5.0M$-6.0M$-8.0M$-8.0M$-8.0M$-7.0M
EPS$-0.70$-0.42$-0.41$-0.27$-0.55$-0.77$-0.56$-0.70$-0.84$-0.87$-0.86$-0.64

Over the 10 years reported for CervoMed Inc., borrowings decreased from $2.0M in 2016 to $0 in 2025, cash stood at $8.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 4.60 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$17.0M$26.0M$18.0M$24.0M$28.0M$38.0M$4.0M$10.0M$43.0M$23.0M
Current Assets$2.0M$10.0M$9.0M$15.0M$19.0M$38.0M$4.0M$10.0M$43.0M$23.0M
Cash$2.0M$9.0M$8.0M$14.0M$19.0M$37.0M$4.0M$8.0M$9.0M$8.0M
Inventory$0$0$0$0$0$0$0$0$0$0
Receivables$0$0$0$0$0$0$0$1.0M$2.0M$0
Fixed Assets$0$0$0$0$0$0$0$0$0$0
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$0$0$0$0$0$0$30.0M$13.0M
Other Assets$7.0M$7.0M$0$0$0$0$0$0$0$0
Total Liabilities$8.0M$5.0M$3.0M$4.0M$3.0M$3.0M$13.0M$3.0M$4.0M$5.0M
Current Liabilities$4.0M$3.0M$1.0M$2.0M$2.0M$3.0M$13.0M$3.0M$4.0M$5.0M
Borrowings$2.0M$1.0M$0$0$0$0$12.0M$0$0$0
Other Liabilities$6.0M$4.0M$3.0M$4.0M$3.0M$3.0M$1.0M$3.0M$4.0M$5.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$9.0M$21.0M$16.0M$20.0M$25.0M$35.0M$-9.0M$7.0M$39.0M$18.0M

For CervoMed Inc., operating cash flow was positive in 0 of 10 reported years; free cash flow in the latest year was negative at $23.0M; free cash flow was positive in 0 of 10 years.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$-11.0M$-12.0M$-11.0M$-10.0M$-14.0M$-15.0M$-3.0M$-7.0M$-17.0M$-23.0M
Investing Cash Flow$8.0M$-1.0M$0$0$0$0$0$0$-29.0M$18.0M
Financing Cash Flow$0$0$0$4.0M$7.0M$-4.0M$0$10.0M$0$0
Net Cash Flow$0$7.0M$-1.0M$6.0M$4.0M$19.0M$-33.0M$4.0M$1.0M$-1.0M
Free Cash Flow$-11.0M$-13.0M$-11.0M$-10.0M$-14.0M$-15.0M$-3.0M$-7.0M$-17.0M$-23.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.04
EV / EBITDA-0.18
FCF Yield-100.06%
Quick Ratio8.57
Interest Coverage—
Return 1Y-57.48%
Return 3Y-32.00%
Return 5Y-92.82%

CervoMed Inc. (CRVO) financials — frequently asked questions

What is CervoMed Inc.'s annual revenue?

CervoMed Inc. (CRVO) reported annual revenue of $0 in its most recent fiscal year.

What is CervoMed Inc.'s net profit?

CervoMed Inc. (CRVO) reported a net loss of $27.0M in its most recent fiscal year.

What is CRVO EV/EBITDA?

CervoMed Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -0.18. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
CRVO Overview CRVO Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.